Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Change in Inventory: 2022-2025

Historic Change in Inventory for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to -$8,737.

  • bioAffinity Technologies' Change in Inventory fell 98.34% to -$8,737 in Q3 2025 from the same period last year, while for Sep 2025 it was $9,871, marking a year-over-year decrease of 36.13%. This contributed to the annual value of $9,124 for FY2024, which is 29.51% down from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Change in Inventory is -$8,737, which was down 268.38% from $5,189 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Change in Inventory registered a high of $20,281 during Q2 2024, and its lowest value of -$8,997 during Q1 2024.
  • Its 3-year average for Change in Inventory is $2,699, with a median of $2,245 in 2024.
  • Its Change in Inventory has fluctuated over the past 5 years, first skyrocketed by 5,000.57% in 2023, then slumped by 2,182.38% in 2024.
  • Over the past 4 years, bioAffinity Technologies' Change in Inventory (Quarterly) stood at -$175 in 2022, then skyrocketed by 5,000.57% to $8,576 in 2023, then crashed by 73.82% to $2,245 in 2024, then plummeted by 98.34% to -$8,737 in 2025.
  • Its Change in Inventory was -$8,737 in Q3 2025, compared to $5,189 in Q2 2025 and $11,174 in Q1 2025.